Hrt Financial LP Inmune Bio, Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$10.53 - $14.01 $314,825 - $418,870	29,898 New	29,898 $351,000
Q2 2021 Aug 16, 2021	SELL	$9.29 - $19.33 $204,890 - $426,323	-22,055 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.61 - $26.85 $256,058 - $592,176	22,055 New	22,055 $262,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.